Literature DB >> 10723636

Treatment of social phobia with the dopamine agonist pergolide.

G Villarreal, M R Johnson, R Rubey, R B Lydiard, J C Ballanger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10723636     DOI： 10.1002/(sici)1520-6394(2000)11:1<45::aid-da8>3.0.co;2-8

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN： 1091-4269            Impact factor:   6.505


× No keyword cloud information.
  2 in total

Review 1.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

2.  Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.

Authors:  Olof Hjorth; Andreas Frick; Malin Gingnell; Jonas Engman; Johannes Björkstrand; Vanda Faria; Iman Alaie; Per Carlbring; Gerhard Andersson; My Jonasson; Mark Lubberink; Gunnar Antoni; Margareta Reis; Kurt Wahlstedt; Mats Fredrikson; Tomas Furmark
Journal:  Transl Psychiatry       Date:  2022-10-07       Impact factor: 7.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.